140 related articles for article (PubMed ID: 36533956)
21. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.
Lin CH; Tsai CH; Yeh CT; Liang JL; Hung WC; Lin FC; Chang WL; Li HY; Yao YC; Hsu TI; Lee YC; Wang YC; Sheu BS; Lai WW; Calkins MJ; Hsiao M; Lu PJ
Oncotarget; 2016 Jun; 7(26):39680-39693. PubMed ID: 27203740
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
23. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.
Zhuang L; Zhang B; Liu X; Lin L; Wang L; Hong Z; Chen J
Cell Biol Int; 2021 Oct; 45(10):2140-2149. PubMed ID: 34288231
[TBL] [Abstract][Full Text] [Related]
24. MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase.
Han DL; Wang LL; Zhang GF; Yang WF; Chai J; Lin HM; Fu Z; Yu JM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2809-2816. PubMed ID: 31002132
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway.
Qi B; Wang Y; Chen ZJ; Li XN; Qi Y; Yang Y; Cui GH; Guo HZ; Li WH; Zhao S
World J Gastroenterol; 2017 Dec; 23(45):7965-7977. PubMed ID: 29259372
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
Pei K; Zhu JJ; Wang CE; Xie QL; Guo JY
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4697-4704. PubMed ID: 27906433
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-338-5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id-1.
Han L; Cui D; Li B; Xu WW; Lam AKY; Chan KT; Zhu Y; Lee NPY; Law SYK; Guan XY; Qin YR; Chan KW; Ma S; Tsao SW; Cheung ALM
Cancer Sci; 2019 Dec; 110(12):3677-3688. PubMed ID: 31646712
[TBL] [Abstract][Full Text] [Related]
28. Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior.
Li F; Zhou X; Chen M; Fan W
Exp Mol Pathol; 2020 Oct; 116():104491. PubMed ID: 32659236
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
30. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
Li X; Chen D; Li M; Gao X; Shi G; Zhao H
Chem Biol Interact; 2018 May; 288():76-82. PubMed ID: 29680210
[TBL] [Abstract][Full Text] [Related]
31. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
[TBL] [Abstract][Full Text] [Related]
32. miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer.
Yang D; Zhan M; Chen T; Chen W; Zhang Y; Xu S; Yan J; Huang Q; Wang J
Sci Rep; 2017 Mar; 7():43109. PubMed ID: 28256505
[TBL] [Abstract][Full Text] [Related]
33. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
34. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
35. Potential miRNA biomarkers for the diagnosis and prognosis of esophageal cancer detected by a novel absolute quantitative RT-qPCR method.
Lin Z; Chen Y; Lin Y; Lin H; Li H; Su X; Fang Z; Wang J; Wei Q; Teng J; Zhang Z
Sci Rep; 2020 Nov; 10(1):20065. PubMed ID: 33208781
[TBL] [Abstract][Full Text] [Related]
36. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic microRNA-301b regulates tumor repressor dystrobrevin alpha to facilitate cell growth, invasion and migration in esophageal cancer.
Fu G; Pei Z; Song N
Esophagus; 2021 Apr; 18(2):315-325. PubMed ID: 32737801
[TBL] [Abstract][Full Text] [Related]
38. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
[TBL] [Abstract][Full Text] [Related]
39. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy.
Chen G; Peng J; Zhu W; Tao G; Song Y; Zhou X; Wang W
Med Oncol; 2014 Nov; 31(11):263. PubMed ID: 25280517
[TBL] [Abstract][Full Text] [Related]
40. Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network.
Wei L; Gu W; Hu L; Wang K; Huang H; Shen Y
Crit Rev Eukaryot Gene Expr; 2022; 32(6):57-68. PubMed ID: 35997118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
